These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 25837854

  • 1. Puberty suppression and executive functioning: An fMRI-study in adolescents with gender dysphoria.
    Staphorsius AS, Kreukels BP, Cohen-Kettenis PT, Veltman DJ, Burke SM, Schagen SE, Wouters FM, Delemarre-van de Waal HA, Bakker J.
    Psychoneuroendocrinology; 2015 Jun; 56():190-9. PubMed ID: 25837854
    [Abstract] [Full Text] [Related]

  • 2. Psychological Support, Puberty Suppression, and Psychosocial Functioning in Adolescents with Gender Dysphoria.
    Costa R, Dunsford M, Skagerberg E, Holt V, Carmichael P, Colizzi M.
    J Sex Med; 2015 Nov; 12(11):2206-14. PubMed ID: 26556015
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Postnatal Effects of Sex Hormones on Click-Evoked Otoacoustic Emissions: A Study of Adolescents with Gender Dysphoria.
    Burke SM, van Heesewijk JO, Menks WM, Klink DT, Kreukels BPC, Cohen-Kettenis PT, Bakker J.
    Arch Sex Behav; 2020 Feb; 49(2):455-465. PubMed ID: 32056039
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bone mass in young adulthood following gonadotropin-releasing hormone analog treatment and cross-sex hormone treatment in adolescents with gender dysphoria.
    Klink D, Caris M, Heijboer A, van Trotsenburg M, Rotteveel J.
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E270-5. PubMed ID: 25427144
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Male-typical visuospatial functioning in gynephilic girls with gender dysphoria - organizational and activational effects of testosterone.
    Burke SM, Kreukels BP, Cohen-Kettenis PT, Veltman DJ, Klink DT, Bakker J.
    J Psychiatry Neurosci; 2016 Oct; 41(6):395-404. PubMed ID: 27070350
    [Abstract] [Full Text] [Related]

  • 11. Puberty suppression in adolescents with gender identity disorder: a prospective follow-up study.
    de Vries AL, Steensma TD, Doreleijers TA, Cohen-Kettenis PT.
    J Sex Med; 2011 Aug; 8(8):2276-83. PubMed ID: 20646177
    [Abstract] [Full Text] [Related]

  • 12. [Puberty Suppression for Adolescents with Gender Dysphoria A Japanese Perspective].
    Matsumoto Y.
    Seishin Shinkeigaku Zasshi; 2017 Aug; 119(1):42-51. PubMed ID: 30629867
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and Safety of Gonadotropin-Releasing Hormone Agonist Treatment to Suppress Puberty in Gender Dysphoric Adolescents.
    Schagen SE, Cohen-Kettenis PT, Delemarre-van de Waal HA, Hannema SE.
    J Sex Med; 2016 Jul; 13(7):1125-32. PubMed ID: 27318023
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Gonadal suppressive and cross-sex hormone therapy for gender dysphoria in adolescents and adults.
    Smith KP, Madison CM, Milne NM.
    Pharmacotherapy; 2014 Dec; 34(12):1282-97. PubMed ID: 25220381
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.